Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon T Gufford

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|November 22, 2019
Probenecid-Boosted Tenofovir: A Physiologically-Based Pharmacokinetic Model-Informed Strategy for On-Demand HIV Preexposure ProphylaxisStephanie N Liu, Zeruesenay Desta, Brandon T Gufford
Pharmacogenomics|June 9, 2017
Clinical and educational impact of pharmacogenomics testing: a case series from the INGENIOUS trialRebecca C Pierson, Brandon T Gufford, Zeruesenay Desta, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 17, 2025
The strong clinical interaction between bupropion and CYP2D6 is primarily mediated through bupropion metabolites and their stereoisomers: A paradigm for evaluating metabolites in drug-drug interaction riskIrin Tanaudommongkon, Amir Rashidian, Brandon T Gufford, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 24, 2016
Stereoselective Glucuronidation of Bupropion Metabolites In Vitro and In VivoBrandon T Gufford, Jessica Bo Li Lu, Ingrid F Metzger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 29, 2015
Chemoenzymatic Synthesis, Characterization, and Scale-Up of Milk Thistle Flavonolignan GlucuronidesBrandon T Gufford, Tyler N Graf, Noemi D Paguigan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 11, 2014
Identification of diet-derived constituents as potent inhibitors of intestinal glucuronidationBrandon T Gufford, Gang Chen, Philip Lazarus, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 14, 2015
Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product-Drug InteractionBrandon T Gufford, Gang Chen, Ana G Vergara, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 4, 2016
Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy VolunteersAndrea R Masters, Brandon T Gufford, Jessica Bo Li Lu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 27, 2019
Mechanistic Assessment of Extrahepatic Contributions to Glucuronidation of Integrase Strand Transfer InhibitorsStephanie N Liu, Jessica Bo Li Lu, Christy J W Watson, et al.
Journal of Dietary Supplements|March 22, 2012
Physicochemical characterization of creatine N-methylguanidinium saltsBrandon T Gufford, Kamaraj Sriraghavan, Nicholas J Miller, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
CPT: Pharmacometrics & Systems Pharmacology|November 22, 2019
Probenecid-Boosted Tenofovir: A Physiologically-Based Pharmacokinetic Model-Informed Strategy for On-Demand HIV Preexposure ProphylaxisStephanie N Liu, Zeruesenay Desta, Brandon T Gufford
Pharmacogenomics|June 9, 2017
Clinical and educational impact of pharmacogenomics testing: a case series from the INGENIOUS trialRebecca C Pierson, Brandon T Gufford, Zeruesenay Desta, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 17, 2025
The strong clinical interaction between bupropion and CYP2D6 is primarily mediated through bupropion metabolites and their stereoisomers: A paradigm for evaluating metabolites in drug-drug interaction riskIrin Tanaudommongkon, Amir Rashidian, Brandon T Gufford, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 24, 2016
Stereoselective Glucuronidation of Bupropion Metabolites In Vitro and In VivoBrandon T Gufford, Jessica Bo Li Lu, Ingrid F Metzger, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 29, 2015
Chemoenzymatic Synthesis, Characterization, and Scale-Up of Milk Thistle Flavonolignan GlucuronidesBrandon T Gufford, Tyler N Graf, Noemi D Paguigan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 11, 2014
Identification of diet-derived constituents as potent inhibitors of intestinal glucuronidationBrandon T Gufford, Gang Chen, Philip Lazarus, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 14, 2015
Milk Thistle Constituents Inhibit Raloxifene Intestinal Glucuronidation: A Potential Clinically Relevant Natural Product-Drug InteractionBrandon T Gufford, Gang Chen, Ana G Vergara, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 4, 2016
Chiral Plasma Pharmacokinetics and Urinary Excretion of Bupropion and Metabolites in Healthy VolunteersAndrea R Masters, Brandon T Gufford, Jessica Bo Li Lu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 27, 2019
Mechanistic Assessment of Extrahepatic Contributions to Glucuronidation of Integrase Strand Transfer InhibitorsStephanie N Liu, Jessica Bo Li Lu, Christy J W Watson, et al.
Journal of Dietary Supplements|March 22, 2012
Physicochemical characterization of creatine N-methylguanidinium saltsBrandon T Gufford, Kamaraj Sriraghavan, Nicholas J Miller, et al.
Pageof 3